Surprise COVID-19 antibody sales of $804M help Regeneron trounce expectations in third quarter kdunleavy Thu, 11/04/2021 – 11:06 More: Surprise COVID-19 antibody sales of 4M help Regeneron trounce expectations in third quarter Source: fierce
read moreMerck and Ridgeback’s COVID-19 oral antiviral molnupiravir joins the pandemic response with U.K. nod esagonowsky Thu, 11/04/2021 – 10:58 More: Merck and Ridgeback's COVID-19 oral antiviral molnupiravir joins the pandemic response with U.K. nod Source: fierce
read moreNovartis exits 20-year Roche stake, creating a $20.7B question about CEO Vas Narasimhan’s next M&A move aliu Thu, 11/04/2021 – 10:34 More: Novartis exits 20-year Roche stake, creating a .7B question about CEO Vas Narasimhan's next M&A move Source: fierce
read moreShipping delays, supply chain expansions ding Moderna’s COVID-19 vaccine business esagonowsky Thu, 11/04/2021 – 09:42 More: Shipping delays, supply chain expansions ding Moderna's COVID-19 vaccine business Source: fierce
read moreCatalent telegraphs more growth in Indiana with $1.2M land deal: report jkeenan Thu, 11/04/2021 – 09:19 More: Catalent telegraphs more growth in Indiana with .2M land deal: report Source: fierce
read moreThe research paper, published in the Lancet and funded by Cancer Research UK, considered all cervical cancers diagnosed in England among women aged 20-64 between January 2006 and June 2019 More: Researchers find HPV vaccine cuts cervical cancer by 87%
read more© 1994 - 2026 B.M. Pharmaceuticals